More MS news articles for Nov 2001

UK MS Society: Current Research Grants as at  November 19, 2001

November 19, 2001
Grant title Principal grantholder Principal location
Characterisation of adult oligodendrocyte progenitors in the adult CNS with new cell-type specific markers Professor PJ Brophy Edinburgh University
The Multiple Sclerosis Society UK Tissue Bank Professor R Reynolds Imperial College, London
Site directed lesions of demyelination in viral models of MS Dr JK Fazakerley Edinburgh University
Molecules that mediate oligodendrocyte-axon interaction Professor PJ Brophy Edinburgh University
Investigation of brain endothelial cell mechanisms controlling migration into the CNS: Identification of potential therapeutic targets. Greenwood, Professor J Institute of Ophthalmology, London
491/I193398 A magnetic resonance study of the pathogenesis and prognosis of multiple sclerosis Professor DH Miller Institute of Neurology, London
Psychosocial aspects of caring: the role of social support and social networks for carers of people with multiple sclerosis Mrs RA Chesson Robert Gordon University, Aberdeen
Quantitative and in situ studies of human herpesvirus 6 in multiple sclerosis brain tissue Dr DA Clark Royal Free & Uinv. Coll. Med. School
Integrin signalling during oligodendrocyte differentiation ffrench-Constant, Professor C Cambridge University
Chemokine production and function by cells of the adult human nervous system Professor DK Male Open University
Axonal Injury and Disability in Multiple Sclerosis Professor PM Matthews Oxford University
Effects of Inflammation on Conduction in Normal and Demyelinated Central Axons Professor KJ Smith King's College, London
The role of chemokines and their receptors in the pathogenesis of multiple sclerosis Dr MN Woodroofe Sheffield Hallam University
Are T cell epitope spread and Th1 cytokine responses essential for relapsing and remitting EAE? Dr DM Altmann Imperial College, London
In vivo effects of fibroblast growth factor on oligodendrocytes and myelination Dr AM Butt King's College, London
An in vitro study of the role of matrix metalloproteinase and chemokines in CNS inflammation Dr MN Woodroofe Sheffield Hallam University
Virus induced apoptosis of glial cells Dr JK Fazakerley University of Edinburgh
HLA class II/human anti-MBP T cell receptor transgenics: T cell selection, disease protection and repair Dr DM Altmann Imperial College, London
A role for transforming growth factor beta1 in neuritogenesis and myelinogenesis in macrophage-enriched CNS aggregate cultures: implications for MS Dr L Diemel Institute of Neurology, London
The biology, behaviour and myelinating potential of immortalised cells of the adult human oligodendrocyte lineage Dr NJ Scolding Bristol University
Control of relapsing disease in models of MS Dr D Baker Institute of Neurology, London
Axo-oligodendroglial signals to promote remyelination Dr L Wrabetz H San Raffaele, Milan, Italy
A trial of intravesical atropine for detrusor hyperreflexia in multiple sclerosis Professor JG Malone-Lee UCL, London
Rehabilitation of Multiple Sclerosis Dr Deirdre Walsh Ulster University
MS Society Senior Research Fellowship in Scotland Professor P Kennedy Glasgow University
MS Society Senior Research Fellowship in Scotland Professor S D Logan University of Aberdeen
Restoration of conduction to demyelinated axons: a new pharmacological opportunity Professor KJ Smith King's College, London
Assessment and enhancement of the myelination of transplanted glial cell populations Professor C ffrench-Constant Cambridge University Centre for Brain Repair
The relative effectiveness of information, social support and psychological therapy for enhanced coping in MS Dr CA Young Walton Centre for Neurology & Neurosurgery
Gene therapy by expression of complement regulators in experimental models of demyelination Professor BP Morgan University of Wales, Cardiff
An exploratory study into the perceptions people with multiple sclerosis have of wheelchairs Dr M Rice-Oxley St. Richard's Hospital, Chichester
Schwann cell remyelination in the CNS: are the Schwann cells generated from CNS precurser? Professor WF Blakemore Cambridge University
Multiple sclerosis, MHC and NK receptor genes Professor J Trowsdale Cambridge University
Comprehensive analysis of autoreactive T cells in multiple sclerosis Dr B Jakobsen John Radcliffe Hospital, Oxford
Dendritic cells in acute and immune mediated lesions in the CNS Professor VH Perry Southampton University
Role of impulse activity in axonal degeneration in inflammatory demyelinating disease Professor KJ Smith King's College, London
Do Schwann cell precursors have favourable properties for myelin repair in the CNS? A study using drug- and immune-mediated models and myelin mutants. Professor Jessen KR UCL, London
Temporal appearance and pathogenic role of autoimmunity to myelin oligodendrocyte glycoprotein in the perpetuation and progression of experimental demyelinating disease and MS Principal grantholder  Dr S Amor Imperial College, London
Alpha V integrin function during myelination Professor C ffrench-Constant Cambridge University
Cannabinoids in Multiple Sclerosis Professor AJ Thompson Institute of Neurology, London
The effects of cannabinoids on lower urinary tract symptoms and detrusor hyperreflexia in patients with MS: A multicentre, randomised, double blind controlled trial. (CAMS LUTS) Mr RM Freeman Derriford Hospital
Multiple Sclerosis in Northern Ireland - Do needs and provision correspond for patients and carers? Professor PM Reilly Queen's University, Belfast
The relationship between psycho/social adaptation to multiple sclerosis and coping responses when entering long term residential care Ms Sheila Flynn John Grooms
Management of the diagnostic phase of MS - a comparison of three models Ms Bernadette Porter Institute of Neurology, London
Randomised controlled trial of a patient-specific information handbook for use within a multidisciplinary Multiple Sclerosis clinic Dr Mike Boggild Walton Centre for Neurology & Neurosurgery
A pilot study to evaluate the impact of an education programme on people newly diagnosed with multiple sclerosis Ms Jane Petty Royal Hallamshire Hospital
Identification of cellular and molecular alterations in MS that may affect remyelination. Professor R Reynolds Imperial College, London
Multiple Sclerosis Impact Scale (MSIS-29) : Evaluation of responsiveness in hospital-based samples Dr Jeremy Hobart Institute of Neurology, London
Grant title Role of AP-1 and its possible target Mayven, in oligodendrocyte process formation Dr SC Barnett Glasgow University
Reflexology treatments for people with multiple sclerosis: a controlled study Dr K Booth Manchester University
Do chemokines contribute to blood-brain barrier dysfunction in multiple sclerosis? An in vitro study on astrocytes and brain endothelial cells. Dr IA Romero Open University
The effects of omega-6 fatty acid supplementation on membrane fatty acid composition and cytokines in relapse-remitting multiple sclerosis Dr LS Harbige University of Greenwich
Transcutaneous Electrical Nerve Stimulation : Is it effective in reducing spasticity in Multiple Sclerosis ? Mrs LJ Miller Ayrshire Central Hospital
Evaluation of Respite Care: MS Society Dr I Smith Nuffield Institute for Health
Evaluation of Respite Care: Definition of respite care in the UK; Description of MS Homes; National Policy; Mapping. Mrs RA Chesson Robert Gordon University, Aberdeen
Genetic Analysis of Multiple Sclerosis in EuropeanS (G.A.M.E.S.) Professor DAS Compston Cambridge University
Descriptive Studies of MS Society Homes in Scotland Mrs RA Chesson Robert Gordon University, Aberdeen